Article Versions Notes

Bruno R, Poma AM, Panozzi M, Lenzini A, Elia G, Zirafa CC, Aprile V, Ambrogi MC, Baldini E, Lucchi M, et al. Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive Cohort. Cancers. 2024; 16(7):1410. https://doi.org/10.3390/cancers16071410

Bruno, Rossella, Anello Marcello Poma, Martina Panozzi, Alessandra Lenzini, Gianmarco Elia, Carmelina Cristina Zirafa, Vittorio Aprile, Marcello Carlo Ambrogi, Editta Baldini, Marco Lucchi, and et al. 2024. "Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive Cohort" Cancers 16, no. 7: 1410. https://doi.org/10.3390/cancers16071410

Bruno, R., Poma, A. M., Panozzi, M., Lenzini, A., Elia, G., Zirafa, C. C., Aprile, V., Ambrogi, M. C., Baldini, E., Lucchi, M., Melfi, F., Chella, A., Sbrana, A., & Alì, G. (2024). Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive Cohort. Cancers, 16(7), 1410. https://doi.org/10.3390/cancers16071410